- Neutra Corp. is working to establish its position within the rapidly growing hemp-based product and CBD markets
- The company’s recent acquisition of J3 Holdings will give Neutra Corp. access to J3 Holdings’ land, warehouse and hemp cultivation license, allowing it to ensure the quality of ingredients used in product development
- Neutra Corp. also announced the acquisition of Vivis, an emerging retail brand of hemp-based health and nutritional products that are third-party certified
Neutra Corp. (OTCQB: NTRR), an early stage research and development company focusing on modern healthy living solutions, recently announced a couple of important moves in line with its corporate expansion and vertical integration CBD market strategy.
On July 24, 2019, Neutra Corp. announced its entry into a letter of intent for the acquisition of J3 Holdings (http://cnw.fm/5UxIE), which currently owns land and a warehouse, as well as a license for hemp cultivation and refining into usable forms. Through the move, Neutra will become capable of cultivating, manufacturing and distributing hemp-based CBD products.
For some time, Neutra had been concentrating its efforts on the development of hemp-based CBD products. With the latest acquisition, it aims to become capable of growing its own hemp supply to ensure the quality of ingredients.
On July 26, Neutra Corp. announced another very important acquisition to strengthen its CBD market position even further (http://cnw.fm/L5sVx). The company signed a letter of intent for the acquisition of Vivis, an emerging retail brand of hemp-based health and nutritional products.
Vivis CBD products are third-party certified as containment-free and of consistent quality and potency, Neutra Corp. President Sydney Jim said in a news release. Consumers are becoming more interested in products that have such certification, which could increase the demand for Neutra products upon completion of the Vivis acquisition, he concluded.
Neutra is working to establish its position in the particularly lucrative CBD market. According to industry forecasts, hemp-based product sales could reach $22 billion by 2022. Several factors contribute to the growth, including rapid legalization, higher levels of consumer awareness and significantly more research being conducted into the health benefits of CBD.
The range of CBD products is constantly growing. Currently, it includes oils, creams, supplements, analgesics, beverages, edibles and various others. CBD can also be inhaled to deliver anti-depression benefits, anti-inflammatory effects, pain relief and relief from the symptoms of neurodegenerative disorders like Alzheimer’s and Parkinson’s disease. Unlike other compounds, CBD does not cause addiction. It also avoids the typical high that stems from THC use.
According to Sydney Jim, the CBD market offers tremendous opportunities. This is the main reason why Neutra Corp. will continue targeting the sector moving forward, he concluded.
To cement its market position, Neutra Corp. has been actively looking for partners and acquisitions in the hemp-derived product niche for over eight months.
For more information, visit the company’s website at www.NutraInc.com
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.cbdwire.com
303.498.7722 Office
Editor@CBDWire.com
